Authors: Hammond, SA Tsonis, C Sellins, K Rushlow, K Scharton-Kersten, T Colditz, I Glenn, GM

Citation: Sa. Hammond et al., Transcutaneous immunization of domestic animals: opportunities and challenges, ADV DRUG DE, 43(1), 2000, pp. 45-55

Authors: Scharton-Kersten, T Yu, JM Vassell, R O'Hagan, D Alving, CR Glenn, GM

Citation: T. Scharton-kersten et al., Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants, INFEC IMMUN, 68(9), 2000, pp. 5306-5313

Authors: Glenn, GM Scharton-Kersten, T Vassell, R

Citation: Gm. Glenn et al., Transcutaneous immunization, METH MOL M, 42, 2000, pp. 315-326

Authors: Scharton-Kersten, T Glenn, GM Vassell, R Yu, JM Walwender, D Alving, CR

Citation: T. Scharton-kersten et al., Principles of transcutaneous immunization using cholera toxin as an adjuvant, VACCINE, 17, 1999, pp. S37-S43

Authors: Walker, PS Scharton-Kersten, T Krieg, AM Love-Homan, L Rowton, ED Udey, MC Vogel, JC

Citation: Ps. Walker et al., Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12-and IFN-gamma-dependent mechanisms, P NAS US, 96(12), 1999, pp. 6970-6975

Authors: Glenn, GM Scharton-Kersten, T Vassell, R Matyas, GR Alving, CR

Citation: Gm. Glenn et al., Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants, INFEC IMMUN, 67(3), 1999, pp. 1100-1106